Hyperglycemia as a risk factor for postoperative early wound infection after bicondylar tibial plateau fractures: Determining a predictive model based on four methods.


Journal

Injury
ISSN: 1879-0267
Titre abrégé: Injury
Pays: Netherlands
ID NLM: 0226040

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 27 02 2019
revised: 06 06 2019
accepted: 23 07 2019
pubmed: 3 8 2019
medline: 24 7 2020
entrez: 3 8 2019
Statut: ppublish

Résumé

Identify a glucose threshold that would put patients with isolated bicondylar tibial plateau fractures at risk of early wound infection (i.e. < 90 days). Retrospective review of medical records. Academic American College of Surgeons (ACS) Level 1 trauma center. Adult patients between 2010 and 2015 with an operatively treated isolated bicondylar tibial plateau fracture and at least three glucose measurements during their hospitalization. To predict infection using four different methods: maximum preoperative blood glucose (PBG), maximum blood glucose (MGB), Hyperglycemic Index (HGI), and Time-Weighted Average Glucose (TWAG). 126/381 patients met our inclusion criteria. Fifteen (12%) patients had an open fracture and 30/126 (23%) developed an infection. Median glucose for each predictive method studied was 114 (IQR 101.2-137.8) mg/dL for PBG, 144 (IQR 119-169.8) mg/dL for MBG, 0.8 (IQR 0.20-1.60) mmol/L for HGI, and 120.4 (IQR 106.0-135.6) mg/dL for TWAG. As expected, infected patients had higher PBG, MGB, and TWAG. HGI was similar in both groups. None of these differences prove to be statistically significant (p > .05). Logistic regression models for all the methods showed that having an open fracture was the strongest predictor of infection. It is well known that stress-induced hyperglycemia increases the risk of infection, we present and compare four models that have been used in other medical fields. In our study, none of the methods presented identified a glucose threshold that would increase the risk of infection in patients with bicondylar tibial plateau fractures. Retrospective review, Level III. See Instructions for Authors for a complete description of levels of evidence.

Identifiants

pubmed: 31371170
pii: S0020-1383(19)30427-9
doi: 10.1016/j.injury.2019.07.028
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2097-2102

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Andres Rodriguez-Buitrago (A)

Division of Orthopaedic Trauma, Vanderbilt Medical Center, 1215st Avenue South, Nashville, TN, 37212, United States; Universidad del Rosario, School of Medicine and Health Sciences, Bogotá, Colombia. Electronic address: andres.rodriguez@vumc.org.

Attum Basem (A)

Division of Orthopaedic Trauma, Vanderbilt Medical Center, 1215st Avenue South, Nashville, TN, 37212, United States. Electronic address: basem.a.attum@vumc.org.

Ebubechi Okwumabua (E)

Meharry Medical College, 1005 Dr DB Todd Jr Blvd, Nashville, TN, 37208, United States. Electronic address: neokwumabua17@email.mmc.edu.

Nichelle Enata (N)

Meharry Medical College, 1005 Dr DB Todd Jr Blvd, Nashville, TN, 37208, United States. Electronic address: nharrison17@email.mmc.edu.

Adam Evans (A)

Meharry Medical College, 1005 Dr DB Todd Jr Blvd, Nashville, TN, 37208, United States. Electronic address: aevans17@email.mmc.edu.

Jacquelyn Pennings (J)

Department of Orthopaedics, Vanderbilt Medical Center, 1215 21st Avenue South, Nashville, TN, 37212, United States. Electronic address: jacquelyn.pennings@vanderbilt.edu.

Bernes Karacay (B)

Department of Orthopaedics, Vanderbilt Medical Center, 1215 21st Avenue South, Nashville, TN, 37212, United States. Electronic address: bernes.karacay.1@vumc.org.

Mark John Rice (MJ)

Department of Anesthesiology, Vanderbilt Medical Center, 1215 21st Avenue South, Nashville, TN, 37212, United States. Electronic address: mark.j.rice@vanderbilt.edu.

William Obremskey (W)

Division of Orthopaedic Trauma, Vanderbilt Medical Center, 1215st Avenue South, Nashville, TN, 37212, United States. Electronic address: william.obremskey@Vanderbilt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH